Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate
Yunhan Jiang(Sichuan University), Tao Yang(Sichuan University), Xiaoqiu Xu(Sichuan University), Youfu Luo(Sichuan University), Yingqiang Guo(Sichuan University), Dongmei Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Mengdi Cheng(Sichuan University), Jiasheng Huang(Sichuan University), Meng Zhou(Sichuan University), Pingxian Liu(Sichuan University)
Cited by 18
Related Papers
Forkhead box O proteins: steering the course of stem cell fate
|Cell Regeneration|2024|12
The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective
|European Journal of Medicinal Chemistry|2024|10
CAR-engineered cytolytic Tregs reverse pulmonary fibrosis and remodel the fibrotic niche with limited CRS
|JCI Insight|2025|9
Differences in the content of human milk oligosaccharides between foremilk and hind milk
|Food Bioengineering|2023|6
FoxO is required for neoblast differentiation during planarian regeneration
|International Journal of Biological Macromolecules|2024|5